{"meta":{"query_hash":"abebaf0f6325","filters":{"venue":"Blood and Lymphatic Cancer Targets and Therapy"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/abebaf0f6325","api":"https://metacan.xera.ac/api/v1/cohort?venue=Blood+and+Lymphatic+Cancer+Targets+and+Therapy"},"results":[{"id":"W2052425543","doi":"10.2147/blctt.s44343","title":"MicroRNA dysregulation in B-cell non-Hodgkin lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lymphoma; microRNA; Hodgkin lymphoma; Immune dysregulation; Cancer research; Biology; Immunology; Genetics; Gene; Immune system","score_opus":0.005049668615530808,"score_gpt":0.21923653078871208,"score_spread":0.21418686217318128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052425543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654682,0.03373139,0.0000577252,0.0001681602,0.000059774306,0.0003302025,0.0000076177203,0.00000613616,0.00017075118],"genre_scores_gemma":[0.99191433,0.007029563,0.00023812825,0.00031586635,0.00013500344,0.00009246436,0.000038303137,0.000019309917,0.00021701555],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992744,0.000027950167,0.0001681184,0.0002826587,0.00006570956,0.00018116397],"domain_scores_gemma":[0.99967134,0.000006668711,0.00006832055,0.0001418966,0.0000362596,0.00007553531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006492972,0.00014744577,0.00013441886,0.000045325873,0.00005571616,0.00004644761,0.000054083583,0.00009152495,0.00007675295],"category_scores_gemma":[0.0000029975274,0.00013021792,0.000031791635,0.00005846698,0.000054843716,0.000011679114,0.000027845821,0.000013036889,0.0000023392693],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051720155,0.0001520976,0.020099944,0.00003331465,0.000044529297,0.0000011714943,0.00014241129,0.000011467761,0.89678425,0.000015252277,0.00035746663,0.082306385],"study_design_scores_gemma":[0.008426144,0.00022918181,0.55351603,0.00005097414,0.00003067209,0.000015066419,0.00006354097,0.0007888132,0.4237777,0.00055067736,0.01212626,0.00042495196],"about_ca_topic_score_codex":0.00051175925,"about_ca_topic_score_gemma":0.00004217924,"teacher_disagreement_score":0.5334161,"about_ca_system_score_codex":0.0000110423325,"about_ca_system_score_gemma":0.00005334974,"threshold_uncertainty_score":0.53101325},"labels":[],"label_agreement":null},{"id":"W2498089677","doi":"10.2147/blctt.s84157","title":"Waldenström macroglobulinemia: biology, genetics, and therapy","year":2016,"lang":"en","type":"review","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Stephen's University","funders":"","keywords":"Ibrutinib; Waldenstrom macroglobulinemia; Bruton's tyrosine kinase; Medicine; Lymphoplasmacytic Lymphoma; Rituximab; Oncology; Lymphoma; Macroglobulinemia; CXCR4; Internal medicine; Germline mutation; Cancer research; Immunology; Leukemia; Chronic lymphocytic leukemia; Biology; Mutation; Tyrosine kinase; Genetics; Multiple myeloma; Receptor","score_opus":0.06055768449692186,"score_gpt":0.3826594748749941,"score_spread":0.32210179037807224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498089677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059051155,0.99147236,0.000007961374,0.0003416666,0.0002599964,0.00153596,0.00020230153,0.00005372033,0.00022089346],"genre_scores_gemma":[0.00044438284,0.9958816,0.0002214901,0.0004870822,0.0010476126,0.0002842178,0.000081618084,0.000117298645,0.0014346607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723667,0.00015097554,0.00065279636,0.000967082,0.00028067382,0.00071182987],"domain_scores_gemma":[0.9983208,0.00029888997,0.00026415943,0.00055427535,0.000111202986,0.0004506551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033288178,0.0007422174,0.0021230162,0.00019662004,0.00018750978,0.00009292846,0.00018207791,0.00058496575,0.00046389757],"category_scores_gemma":[0.000029814231,0.00042882017,0.00023824438,0.00016858918,0.0006737959,0.000047564547,0.00013723232,0.00020974521,0.000012876995],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115816496,0.00011314933,0.0001563482,0.0033254158,0.0012353085,0.000046082954,0.00012186406,1.0076424e-8,0.000056008175,0.000088623616,0.0004938384,0.99424756],"study_design_scores_gemma":[0.018833686,0.00042451514,0.000030072159,0.004807313,0.00047818993,0.0009563044,0.000008776453,0.0000103199245,0.000047781275,0.00027666567,0.9736188,0.0005075909],"about_ca_topic_score_codex":0.0006218699,"about_ca_topic_score_gemma":0.000026844087,"teacher_disagreement_score":0.99373996,"about_ca_system_score_codex":0.00061168784,"about_ca_system_score_gemma":0.0035553619,"threshold_uncertainty_score":0.99981636},"labels":[],"label_agreement":null},{"id":"W2772944194","doi":"10.2147/blctt.s132060","title":"Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects","year":2017,"lang":"en","type":"review","venue":"Blood and Lymphatic Cancer Targets and Therapy","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Interleukin-3 receptor; Plasmacytoid dendritic cell; Myeloid leukemia; Medicine; Venetoclax; Immunotherapy; Myeloid; Leukemia; Lymphoma; Oncology; Immunology; Cancer research; Internal medicine; Cancer; Dendritic cell; Immune system; Chronic lymphocytic leukemia","score_opus":0.06908194046716576,"score_gpt":0.3568258328567061,"score_spread":0.28774389238954035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772944194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002112271,0.9939757,4.3919223e-7,0.00045598557,0.00022965379,0.0018736175,0.00007009249,0.000038492602,0.00124372],"genre_scores_gemma":[0.0014099309,0.9956579,0.00004640287,0.000111945104,0.0009749846,0.00042483403,0.000033380707,0.00010982723,0.0012307761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977174,0.00010039543,0.00041293146,0.0008623793,0.00035642582,0.00055049366],"domain_scores_gemma":[0.9986269,0.00018708326,0.00025137494,0.00043727094,0.00010609126,0.0003913019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016411518,0.00069354725,0.002107164,0.00020417458,0.00038351168,0.00018410989,0.00014782952,0.00034507364,0.00010451948],"category_scores_gemma":[0.000030101819,0.00048517436,0.0001787222,0.00007069379,0.00034755195,0.00008426263,0.00009326347,0.00023375322,0.0000051142283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009675906,0.00024981206,0.00012266405,0.021625953,0.0006840899,0.00027646936,0.0007947653,1.3318651e-8,0.000008576667,0.0001322019,0.0000636567,0.97594506],"study_design_scores_gemma":[0.0053709955,0.0007232636,0.00018074176,0.005567385,0.001127647,0.00319442,0.00016099462,0.000016868262,0.000023889343,0.0001895948,0.9828543,0.00058991346],"about_ca_topic_score_codex":0.00007605672,"about_ca_topic_score_gemma":0.00008632637,"teacher_disagreement_score":0.98279065,"about_ca_system_score_codex":0.000059040292,"about_ca_system_score_gemma":0.00070928945,"threshold_uncertainty_score":0.99976},"labels":[],"label_agreement":null}]}